BioNet News, Events 15 Jan 2026 The European Commission Grants Marketing Authorisation for a First-of-its-Kind Pertussis-Only Vaccine for Vaccination of Teenagers, Adults and Pregnant Women in the European Union Supachai
BioNet News, Events 21 Nov 2025 BioNet Receives Positive CHMP Opinion from EMA for VacPertagen, a Recombinant Vaccine Against Pertussis Bangkok, November 21, 2025 - BioNet, a biotechnology company dedicated to innovative vaccines, announced today that the Committee for Medicinal… Supachai
BioNet News, Events 17 Nov 2025 BioNet Achieves EU-GMP Certification for its Pertussis Vaccine Manufacturing Lyon, France – October 29, 2025, BioNet today announced it has received European Union Good Manufacturing Practice (EU-GMP) certification, an… Pantitra
BioNet News 30 Jul 2024 Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence Pertussis, caused by Bordetella pertussis, is a highly contagious respiratory disease that poses a significant risk to young infants, resulting in both severe morbidity… Pantitra
